PP
STIM icon

PDT Partners’s Neuronetics STIM Stock Holding History

PDT Partners’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,850
Closed -$74.5K – 710
2022
Q4 		$74.5K Sell
10,850
-1,168
-10% -$5.51K 0.01% 590
2022
Q3 		$38K Buy
+12,018
New +$43.7K 0.01% 813

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

PDT Partners's STIM Position: Q1 2023 in Review

PDT Partners sold out of Neuronetics (STIM) in Q1 2023, closing a stake of 10,850 shares — an estimated $74.5K sold.

PDT Partners first reported a position in STIM in Q3 2022 and held it in 2 quarters. The position peaked at $74.5K in Q4 2022. 74 funds tracked by Wall St. Rank hold STIM as of Q1 2023.

  • PDT Partners reported no remaining Neuronetics position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 10,850 Neuronetics shares in Q1 2023, an estimated $74.5K.
  • PDT Partners first reported a position in Neuronetics in Q3 2022 and held it in 2 quarters.
  • PDT Partners's Neuronetics position peaked at $74.5K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Neuronetics as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.